⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21959653 | 0.73 | — | — | |
| SCHEMBL23937785 | 0.71 | — | — | |
| SCHEMBL20631056 | 0.69 | — | — | |
| SCHEMBL23937787 | 0.67 | NOTUM (0.32) | — | |
| SCHEMBL21958541 | 0.66 | ADORA2A (0.40) | — | |
| SCHEMBL21958622 | 0.66 | — | — | |
| SCHEMBL31673224 | 0.63 | — | — | |
| SCHEMBL21958539 | 0.63 | CNOT7 (0.31) | — | |
| SCHEMBL21958542 | 0.62 | ADORA3 (0.34) | — | |
| SCHEMBL20674564 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3399968-B1 | SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE | CS PHARMATECH LTD (KY) | 2021-10-20 | — | — | EP | disclosed |
| US-20200131176-A1 | SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE | CS PHARMATECH LIMITED (KY) | 2020-04-30 | — | — | US | disclosed |